151 related articles for article (PubMed ID: 29637813)
1. Human iPS Cell-based Liver-like Tissue Engineering at Extrahepatic Sites in Mice as a New Cell Therapy for Hemophilia B.
Okamoto R; Takayama K; Akita N; Nagamoto Y; Hosokawa D; Iizuka S; Sakurai F; Suemizu H; Ohashi K; Mizuguchi H
Cell Transplant; 2018 Feb; 27(2):299-309. PubMed ID: 29637813
[TBL] [Abstract][Full Text] [Related]
2. Autologous and Heterologous Cell Therapy for Hemophilia B toward Functional Restoration of Factor IX.
Ramaswamy S; Tonnu N; Menon T; Lewis BM; Green KT; Wampler D; Monahan PE; Verma IM
Cell Rep; 2018 May; 23(5):1565-1580. PubMed ID: 29719266
[TBL] [Abstract][Full Text] [Related]
3. Engineering liver tissues under the kidney capsule site provides therapeutic effects to hemophilia B mice.
Ohashi K; Tatsumi K; Utoh R; Takagi S; Shima M; Okano T
Cell Transplant; 2010; 19(6):807-13. PubMed ID: 20573301
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte-Like Cells Derived From Mouse Induced Pluripotent Stem Cells Produce Functional Coagulation Factor IX in a Hemophilia B Mouse Model.
Wu YM; Huang YJ; Chen P; Hsu YC; Lin SW; Lai HS; Lee HS
Cell Transplant; 2016; 25(7):1237-46. PubMed ID: 26395869
[TBL] [Abstract][Full Text] [Related]
5. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
[TBL] [Abstract][Full Text] [Related]
6. Modeling of Hepatic Drug Metabolism and Responses in CYP2C19 Poor Metabolizer Using Genetically Manipulated Human iPS cells.
Deguchi S; Yamashita T; Igai K; Harada K; Toba Y; Hirata K; Takayama K; Mizuguchi H
Drug Metab Dispos; 2019 Jun; 47(6):632-638. PubMed ID: 30962288
[TBL] [Abstract][Full Text] [Related]
7. Agonist c-Met Monoclonal Antibody Augments the Proliferation of hiPSC-derived Hepatocyte-Like Cells and Improves Cell Transplantation Therapy for Liver Failure in Mice.
Yuan L; Zhang Y; Liu X; Chen Y; Zhang L; Cao J; Li X; Wang M; Wu K; Zhang J; Liu G; Tang Q; Yuan Q; Cheng T; Xia N
Theranostics; 2019; 9(7):2115-2128. PubMed ID: 31037160
[No Abstract] [Full Text] [Related]
8. Transplantation of a human iPSC-derived hepatocyte sheet increases survival in mice with acute liver failure.
Nagamoto Y; Takayama K; Ohashi K; Okamoto R; Sakurai F; Tachibana M; Kawabata K; Mizuguchi H
J Hepatol; 2016 May; 64(5):1068-1075. PubMed ID: 26778754
[TBL] [Abstract][Full Text] [Related]
9. Efficient Engraftment of Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells in uPA/SCID Mice by Overexpression of FNK, a Bcl-xL Mutant Gene.
Nagamoto Y; Takayama K; Tashiro K; Tateno C; Sakurai F; Tachibana M; Kawabata K; Ikeda K; Tanaka Y; Mizuguchi H
Cell Transplant; 2015; 24(6):1127-38. PubMed ID: 24806294
[TBL] [Abstract][Full Text] [Related]
10. Hepatic maturation of human iPS cell-derived hepatocyte-like cells by ATF5, c/EBPα, and PROX1 transduction.
Nakamori D; Takayama K; Nagamoto Y; Mitani S; Sakurai F; Tachibana M; Mizuguchi H
Biochem Biophys Res Commun; 2016 Jan; 469(3):424-9. PubMed ID: 26679606
[TBL] [Abstract][Full Text] [Related]
11. Engraftment of human induced pluripotent stem cell-derived hepatocytes in immunocompetent mice via 3D co-aggregation and encapsulation.
Song W; Lu YC; Frankel AS; An D; Schwartz RE; Ma M
Sci Rep; 2015 Nov; 5():16884. PubMed ID: 26592180
[TBL] [Abstract][Full Text] [Related]
12. Expression of coagulation factors from murine induced pluripotent stem cell-derived liver cells.
Kasuda S; Tatsumi K; Sakurai Y; Kato J; Taminishi S; Takeda T; Ohashi K; Okano T; Hatake K; Shima M
Blood Coagul Fibrinolysis; 2011 Jun; 22(4):271-9. PubMed ID: 21415711
[TBL] [Abstract][Full Text] [Related]
13. Genetic modification of donor hepatocytes improves therapeutic efficacy for hemophilia B in mice.
Wu YM; Kao CY; Huang YJ; Yu IS; Lee HS; Lai HS; Lee PH; Lin CN; Lin SW
Cell Transplant; 2010; 19(9):1169-80. PubMed ID: 20412633
[TBL] [Abstract][Full Text] [Related]
14. Human induced-pluripotent stem cell-derived hepatocyte-like cells as an in vitro model of human hepatitis B virus infection.
Sakurai F; Mitani S; Yamamoto T; Takayama K; Tachibana M; Watashi K; Wakita T; Iijima S; Tanaka Y; Mizuguchi H
Sci Rep; 2017 Apr; 7():45698. PubMed ID: 28374759
[TBL] [Abstract][Full Text] [Related]
15. Liver tissue engineering at extrahepatic sites in mice as a potential new therapy for genetic liver diseases.
Ohashi K; Waugh JM; Dake MD; Yokoyama T; Kuge H; Nakajima Y; Yamanouchi M; Naka H; Yoshioka A; Kay MA
Hepatology; 2005 Jan; 41(1):132-40. PubMed ID: 15619229
[TBL] [Abstract][Full Text] [Related]
16. [Generation of Zone-specific Hepatocyte-like Cells from Human Induced Pluripotent Stem Cells for Accurate Prediction of Drug-induced Hepatotoxicity].
Mitani S
Yakugaku Zasshi; 2019; 139(12):1509-1512. PubMed ID: 31787637
[TBL] [Abstract][Full Text] [Related]
17. Generation of safe and therapeutically effective human induced pluripotent stem cell-derived hepatocyte-like cells for regenerative medicine.
Takayama K; Akita N; Mimura N; Akahira R; Taniguchi Y; Ikeda M; Sakurai F; Ohara O; Morio T; Sekiguchi K; Mizuguchi H
Hepatol Commun; 2017 Dec; 1(10):1058-1069. PubMed ID: 29404442
[TBL] [Abstract][Full Text] [Related]
18. Generation of Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells for Cellular Medicine.
Deguchi S; Takayama K; Mizuguchi H
Biol Pharm Bull; 2020; 43(4):608-615. PubMed ID: 32238703
[TBL] [Abstract][Full Text] [Related]
19. Generation of hepatocyte-like cells from human induced pluripotent stem (iPS) cells by co-culturing embryoid body cells with liver non-parenchymal cell line TWNT-1.
Javed MS; Yaqoob N; Iwamuro M; Kobayashi N; Fujiwara T
J Coll Physicians Surg Pak; 2014 Feb; 24(2):91-6. PubMed ID: 24491001
[TBL] [Abstract][Full Text] [Related]
20. Cell Therapy Using Human Induced Pluripotent Stem Cell-Derived Renal Progenitors Ameliorates Acute Kidney Injury in Mice.
Toyohara T; Mae S; Sueta S; Inoue T; Yamagishi Y; Kawamoto T; Kasahara T; Hoshina A; Toyoda T; Tanaka H; Araoka T; Sato-Otsubo A; Takahashi K; Sato Y; Yamaji N; Ogawa S; Yamanaka S; Osafune K
Stem Cells Transl Med; 2015 Sep; 4(9):980-92. PubMed ID: 26198166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
